Newsroom

Parexel was recognized as a World’s Top Disability Inclusive Business based on its high performance on the Disability Index®, the leading global benchmark for disability inclusion in business. This recognition reflects a company-wide commitment to creating an environment where colleagues and patients – regardless of physical ability or other differences – can participate and thrive in clinical research.

Parexel received a 2026 Triangle Business Journal (TBJ) Life Sciences Award in the Most Innovative Clinical Research Organization (CRO) category. These awards recognize individuals and organizations advancing innovation across the life sciences, including biotechnology, pharmaceuticals, clinical research, medical devices, diagnostics and human health. Parexel was recognized for our industry-leading clinical development impact, combining regulatory leadership, therapeutic expertise, AI driven innovation and meaningful Triangle community leadership that advances biomedical R&D.

Parexel was named the winner of the 2026 NEXT Award for Patient Leadership from Medidata Solutions. This award recognizes Parexel’s commitment to patient-focused technology and patient insights to improve the clinical trial experience and decrease burden on trial participants. Award winners were recognized at Medidata NEXT in NYC on March 11.

Parexel was recognized in the Human Rights Campaign Foundation’s 2026 Corporate Equality Index for our commitment to LGBTQ+ equality and inclusion. The recognition – with a five-point score increase from the previous year – reflects the dedication of our Global Inclusion team’s leadership, advocacy of our Parexel Pride business resource group, and commitment of our global colleagues who champion inclusion every day. The Human Rights Campaign Foundation’s State of the Workplace for LGBTQ+ Americans and Corporate Equality Index 2026 provides a research-based snapshot of LGBTQ+ experiences in U.S. workplaces and a national benchmark of corporate policies, practices, and benefits pertinent to LGBTQ+ employees.